Because of the effort of the investigations about idiopathic pulmonary fibrosis treatment, known as the most aggressive and lethal lung disease, mexican scientists from the Respiratory Diseases National Institute “Ismael Cosio Villegas”, received a recognition by the American Thoracic Society.

The experts, leaded by doctor Moises Selman Lama, became the very first non american scientists who received the recognition, by ranking between the world’s most important group of specialists dedicated to the study of this medical condition.

Among its most significant contributions, highlights a medical study, presented together with National Autonomous University of Mexico, about the idiopathic cystic fibrosis, which demonstrates that it’s not about an inflammatory chronic condition, as they knew half century ago.

The article published with the title: “Idiopathic pulmonary fibrosis: prevailing and in evolution. Hypothesis about pathogenesis and implications for the therapy”, allowed knowing some mechanisms that made this disease more understandable.

As a result of that, the treatment was modified; it was based on powerful anti-inflammatory and immunosuppressant medication, that wasn’t effectively to stop the disease, and created severs secondary effects to the patients.

Doctor Selman Lama pointed that the studies provide modifications in the treatment, as well as in the assignations of resources by the Health Institutes of the United States, who didn’t finance investigations that consider the disease as an inflammatory process.

From that work, they started to make clinical rehearses with another kind of substances for this disease treatment, which allowed the authorization of new medications by the Food and Drug Administration (FDA).

In 1936, during the presidency of the General Lázaro Cardenas, was founded with the name of Sanatorium for Tuberculosis Patients of Huipulco, and in 1982, became the Respiratory Diseases National Institute, with the assignments of medical and educational assistance, as well as scientific and technical researching with specialty on neumology.

Follow us on Twitter: @SSalud_mx y @_MJuan_